Munich Startup
Vantis secures €10 million in Series A

Vantis secures €10 million in Series A

Regina Bruckschlögl

Regina Bruckschlögl

Nach eigenen Startup-Erfahrungen blickt sie als Redakteurin von Munich Startup nun aus einer anderen Perspektive auf die Münchner Startup-Szene – und entdeckt dabei jeden Tag, wie vielfältig das Münchner Ökosystem ist. Startup Stories, die erzählt werden wollen!

March 14, 2025

3 min. read time

Vantis has successfully raised €10 million in a Series A funding round. The Munich healthtech startup, which specializes in the care of chronically ill patients and covers the entire spectrum of primary care services, receives support from prominent investors including Angelini Ventures, Bayern Kapital, and Twip Impact Ventures. Existing investors Firstminute and B2venture also participated again in the round.

Primary care in transition

Germany faces an urgent challenge in primary care. The shortage of physicians, particularly in rural regions, is intensifying, while the number of chronically ill patients continues to grow. Vantis addresses this challenge with a combination of technology-driven efficiency improvements and optimized practice organization. Through the use of digital solutions and data-based treatment methods, the aim is to increase the number of treatable patients per doctor. The Munich startup wants to enable more intensive and data-supported care, particularly for chronically ill people. Digital therapeutic approaches and telemedicine, combined with remote monitoring and AI-supported processes, are intended to create a digital infrastructure for primary care.

Targeted expansion of digital health services

The new capital is to be invested in expanding data-driven management of chronically ill patients. Vantis aims to relieve medical staff and sustainably improve treatment outcomes for patients by building digitally connected care structures. The company relies on AI to further optimize processes and increase efficiency in patient care. Till Jansen, co-founder and CEO of Vantis, says:

“Significant investments are necessary for the digital transformation of the health system so that everyone benefits in the end – physicians, patients, and payers. As a digital health company with our own practices, we have the unique opportunity to tailor our technology specifically to current and future challenges in primary care and continuously optimize it. Our goal is to achieve better treatment outcomes for patients and make doctors’ working lives easier so they can focus more on medical care.”

Questioning the status quo

And Monika Steger, Managing Director of Bayern Kapital, adds:

“We invest in young companies that are ready to question the status quo and bring innovations to the market. By combining its own primary care practices with complementary innovative digital health applications, Vantis aims to sustainably improve primary care for physicians and patients. This forward-thinking strategy makes Vantis a promising investment for us. The company offers a solution that captures the spirit of the times and addresses growing demands in the health market. Moreover, Vantis convinces us both with a diversified, solid business model and attractive growth prospects.”

More like this

Related Articles to Read Next

15 million for Defencetech Project Q
Deals

15 million for Defencetech Project Q

16.07.26
2 Min.
Sherpa scales AI platform with 2 million euros
Deals

Sherpa scales AI platform with 2 million euros

14.07.26
2 Min.
Helsing closes billion-euro funding round
Deals

Helsing closes billion-euro funding round

14.07.26
2 Min.
Just under 3 million euros for Finto
Deals

Just under 3 million euros for Finto

13.07.26
3 Min.
91 million euros total for Quantum Diamonds
Deals

91 million euros total for Quantum Diamonds

10.07.26
2 Min.
€411 million: Proxima Fusion becomes Europe’s most valuable fusion company
Deals

€411 million: Proxima Fusion becomes Europe’s most valuable fusion company

09.07.26
3 Min.